4.4 Article

Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control

Related references

Note: Only part of the references are listed.
Article Neurosciences

Varenicline Improves Mood and Cognition During Smoking Abstinence

Freda Patterson et al.

BIOLOGICAL PSYCHIATRY (2009)

Article Neurosciences

Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers

Sherry A. McKee et al.

BIOLOGICAL PSYCHIATRY (2009)

Article Pharmacology & Pharmacy

The Smoking Cessation Medication Varenicline Attenuates Alcohol and Nicotine Interactions in the Rat Mesolimbic Dopamine System

Mia Ericson et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)

Article Neurosciences

The influence of mecamylamine on ethanol and sucrose self-administration

Matthew M. Ford et al.

NEUROPHARMACOLOGY (2009)

Article Behavioral Sciences

Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice

Danielle Gulick et al.

NEUROBIOLOGY OF LEARNING AND MEMORY (2008)

Article Multidisciplinary Sciences

Varenicline, an α402 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

Pia Steensland et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Substance Abuse

Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers

Suchitra Krishnan-Sarin et al.

DRUG AND ALCOHOL DEPENDENCE (2007)

Article Cardiac & Cardiovascular Systems

Smoking cessation efficacy and safety of varenicline, an α4β2 nicotinic receptor partial agonist

Serena Tonstad

JOURNAL OF CARDIOVASCULAR NURSING (2006)

Article Psychology, Multidisciplinary

Alcohol, neurotransmitter systems, and behavior

Garvin Chastain

JOURNAL OF GENERAL PSYCHOLOGY (2006)

Article Pharmacology & Pharmacy

Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors

Karla B. Mihalak et al.

MOLECULAR PHARMACOLOGY (2006)

Article Medicine, General & Internal

Effect of maintenance therapy with varenicline on smoking cessation - A randomized controlled trial

Serena Tonstad et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Article Neurosciences

Behavioral disinhibition requires dopamine receptor activation

Marcel M. van Gaalen et al.

PSYCHOPHARMACOLOGY (2006)

Article Medicine, General & Internal

Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial

RF Anton et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Article Chemistry, Medicinal

Varenicline:: An α4β2 nicotinic receptor partial agonist for smoking cessation

JW Coe et al.

JOURNAL OF MEDICINAL CHEMISTRY (2005)

Article Psychiatry

Neuropsychological functioning and alcohol dependence

A Scheurich

CURRENT OPINION IN PSYCHIATRY (2005)

Review Pharmacology & Pharmacy

Neurobiology of relapse to alcohol in rats

AD Lê et al.

PHARMACOLOGY & THERAPEUTICS (2002)

Article Neurosciences

Cognitive effects of nicotine

AH Rezvani et al.

BIOLOGICAL PSYCHIATRY (2001)

Review Behavioral Sciences

Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol

B Söderpalm et al.

BEHAVIOURAL BRAIN RESEARCH (2000)